FDA recall D-0181-2023

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon · Class I · drug

Product

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

Reason for recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Distribution

Nationwide in the USA.

Key facts

Status: Terminated
Initiation date: 2022-12-06
Report date: 2023-02-01
Termination date: 2024-02-26
Voluntary/Mandated: Voluntary: Firm initiated
Location: Warren, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0181-2023